Evidence map›Paper›PMID 20858905›Full record

SynthesisCirculation. Cardiovascular genetics2010

Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease.

Kiran Musunuru, Wendy S Post, William Herzog, Haiqing Shen, Jeffrey R O'Connell, Patrick F McArdle, Kathleen A Ryan, Quince Gibson, Yu-Ching Cheng, Elizabeth Clearfield and 12 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Circulation. Cardiovascular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Relevance of Multi-Omics Studies in Cardiovascular Diseases.Frontiers in cardiovascular medicine · 2019
    Review
  9. Article
  10. Long Noncoding RNAFrontiers in cardiovascular medicine · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Platelet signaling.Handbook of experimental pharmacology · 2012
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Kiran MusunuruDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Wendy S Post
William Herzog
Haiqing Shen
Jeffrey R O'Connell
Patrick F McArdle
Kathleen A Ryan
Quince Gibson
Yu-Ching Cheng
Elizabeth Clearfield
Andrew D Johnson
Geoffrey Tofler
Qiong Yang
Christopher J O'Donnell
Diane M Becker
Lisa R Yanek
Lewis C Becker
Nauder Faraday
Lawrence F Bielak
Patricia A Peyser
Alan R Shuldiner
Braxton D Mitchell
National Heart Lung and Blood Institute · USUniversity of Sydney · AUJohns Hopkins University · USRoyal North Shore Hospital · AUUnited States Department of Veterans Affairs · USJohns Hopkins Medicine · USUniversity of Michigan–Ann Arbor · USFramingham Heart Study · US

Funding

Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI OSWALD, LYNN M · 2002 to 2009
$20.2M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2005 to 2019
$17.3M
Genotypic Determinants of Aspirin Response in High Risk FamiliesU01HL072518 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BECKER, LEWIS C · 2002 to 2008
$12.8M
Genome-wide Search for CVD Gene-Environment InteractionsU01HL072515 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2002 to 2008
$11.2M
Genomic Epidemiology of Cardiovascular DiseaseZIAHL006002 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI O'DONNELL, CHRISTOPHER · 2009 to 2015
$8.0M
Genome-Wide Association of Platelet PhenotypesR01HL087698 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BECKER, LEWIS C · 2007 to 2009
$3.8M
Genetic Influences on Coronary Artery CalcificationR01HL088119 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2007 to 2010
$2.8M
SLEEP AND ENTRAINMENT OF SCN FUNCTIONR01HL064278 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI STROHL, KINGMAN PERKINS · 1999 to 2002
$871k
NOVEL HEMOSTATIC CARDIAC RISK FACTORS IN FRAMINGHAMR01HL048157 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MITTLEMAN, MURRAY A · 1994 to 1997
–
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NCRR NIH HHS M01 RR016500NCRR NIH HHS M01 RR 16500NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N02 HL064278NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL048157NHLBI NIH HHS R01 HL087698NHLBI NIH HHS R01 HL088119NHLBI NIH HHS R01 HL48157NHLBI NIH HHS U01 HL072515NHLBI NIH HHS U01 HL072518NHLBI NIH HHS U01 HL72515NHLBI NIH HHS U01 HL72518NIDDK NIH HHS P30 DK072488
6 · The paper itself

Abstract

backgroundGenome-wide association studies have identified a locus on chromosome 9p21.3 to be strongly associated with myocardial infarction/coronary artery disease and ischemic stroke. To gain insights into the mechanisms underlying these associations, we hypothesized that single nucleotide polymorphisms (SNPs) in this region would be associated with platelet reactivity across multiple populations. METHODS AND

resultsSubjects in the initial population included 1402 asymptomatic Amish adults in whom we measured platelet reactivity (n=788) and coronary artery calcification (CAC) (n=939). Platelet reactivity on agonist stimulation was measured by impedance aggregometry, and CAC was measured by electron beam CT. Twenty-nine SNPs at the 9p21.3 locus were genotyped using the Affymetrix 500K array. Twelve correlated SNPs in the locus were significantly associated with platelet reactivity (all P≤0.001). The SNP most strongly associated with platelet reactivity, rs10965219 (P=0.0002), also was associated with CAC (P=0.002) along with 9 other SNPs (all P<0.004). Association of rs10965219 with platelet reactivity persisted after adjustment for CAC, a measure of underlying atherosclerotic burden known to affect platelet reactivity. We then tested rs10965219 for association with platelet function in 2364 subjects from the Framingham Heart Study and 1169 subjects from the Genetic Study of Aspirin Responsiveness. The rs10965219 G allele (frequency ≈51% across all 3 populations) was significantly associated with higher platelet reactivity in the Framingham Heart Study (P=0.001) and trended toward higher reactivity in the Genetic Study of Aspirin Responsiveness (P=0.087); the combined P value for metaanalysis was 0.0002.

conclusionsThese results suggest that risk alleles at 9p21.3 locus may have pleiotropic effects on myocardial infarction/coronary artery disease and stroke risk, possibly through their influence on platelet reactivity.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultBlood PlateletsChromosomes, Human, Pair 9EthnicityFemaleGenotypeHumansMaleMiddle AgedMyocardial InfarctionPlatelet AggregationVascular Diseases

Identifiers

PMID20858905
PMCPMC3031788
OpenAlexW2113308396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.